ADSC-Exos |
Adipose tissue and inguinal fat pads |
A circular shape with concave sides ranging from 20–300 nm diameter. |
CD9, CD63, CD81, TSG101, Hsp70, Hsp90, PPARγ2, leptin, adiponectin |
This source is rich in reserves and easy to access. The proteins of ADSC-Exos mainly involve immune responses of leukocyte activation. |
Wound healing, inflammation suppression, and musculoskeletal disorder treatment; eg, osteoporosis, osteoarthritis, and tendon injury. |
[44,47] |
BMSC-Exos |
Bone marrow |
A round or elliptical shape ranging from 50–150 nm diameter. |
CD9, CD44, CD63, CD81, Alix, TSG101, Hsp70, flotillin-1, sntenin1 |
BMSC-Exos have good osteogenesis and chondrogenicity potential and excellent biocompatibility (B7). |
Organ tissue regeneration and bone metabolism-related disease; eg, osteoporosis, fracture, and incomplete bone healing. |
[50,51] |
HUCMSC-Exos |
Umbilical cord |
A spherical morphology ranging from 40–100 nm diameter. |
CD9, CD63, CD81, Alix, TSG101 |
HucMSC-Exos have high proliferation and self-renewal rates. They alleviate oxidative stress and strengthen vascular remodeling. |
Brain injury and kidney disease repair and wound healing; eg, photodamage, burns, skin injury, and scar formation. |
[52,53] |
SFMSCs-Exos |
Synovial fluid in arthritis |
Diameters ranging from 60–120 nm. |
CD9, CD63, CD81, TSG101 |
Local MSC-Exos may have priority in promoting remodeling. They express the hyaluronan receptor CD44 and synthesize enzymes. |
Mainly applied to localized joints for disease treatment; eg, rheumatoid arthritis, gout, and osteoarthritis. |
[14,54] |